Introduction: Emphysematous pyelonephritis (EPN) is an acute, severe, necrotizing infection of the renal parenchyma and perirenal tissue that requires immediate treatment. However, the ideal approach to its management remains controversial. We conducted this study to determine the appropriate treatment modalities. Materials and Methods: A retrospective review of EPN cases revealed 10 consecutive cases from July 2003 to June 2012. Clinical and demographic data were collected from each patient. Results: All patients had diabetes mellitus, 5 presented with urinary tract obstruction by urolithiasis. Seven patients had type I disease and 3 had type II disease. Six of the type I patients underwent emergent nephrectomy and 1 of these died, the remaining patient refused surgical intervention and died after receiving medical management only. The type II patients underwent percutaneous drainage, and 2 of them subsequently underwent elective nephrectomy; all 3 survived. Conclusion: Our results suggest that emergency nephrectomy may be considered the initial management for type I EPN, while percutaneous drainage may be an effective initial treatment option for type II EPN.

Keywords:
Emphysematous pyelonephritis, Emergency nephrectomy, Percutaneous drainage
1.
Shokeir AA, El-Azab M, Mohsen T, El-Diasty T: Emphysematous pyelonephritis: a 15-year experience with 20 cases. Urology 1997;49:343-346.
2.
Ahlering TE, Boyd SD, Hamilton CL, et al: Emphysematous pyelonephritis: a 5-year experience with 13 patients. J Urol 1985;134:1086-1088.
3.
Pontin AR, Barnes RD, Joffe J, Kahn D: Emphysematous pyelonephritis in diabetic patients. Br J Urol 1995;75:71-74.
4.
Michaeli J, Mogle P, Perlberg S, Heiman S, Caine M: Emphysematous pyelonephritis. J Urol 1984;131:203-208.
5.
Somani BK, Nabi G, Thorpe P, et al: Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review. J Urol 2008;179:1844-1849.
6.
Hudson MA, Weyman PJ, van der Vliet AH, Catalona WJ: Emphysematous pyelonephritis: successful management by percutaneous drainage. J Urol 1986;136:884-886.
7.
Tang HJ, Li C, Yen MY, et al: Clinical characteristics of emphysematous pyelonephritis. J Microbiol Immunol Infect 2001;34:125-130.
8.
Khaira A, Gupta A, Rana DS, Gupta A, Bhalla A, Khullar D: Retrospective analysis of clinical profile, prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis. Int Urol Nephrol 2009;41:959-966.
9.
Wan YL, Lee TY, Bullard MJ, Tsai CC: Acute gas-producing bacterial renal infection: correlation between imaging findings and clinical outcome. Radiology 1996;198:433-438.
10.
Falagas ME, Alexiou VG, Giannopoulou KP, Siempos II: Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis. J Urol 2007;178:880-885.
11.
Huang JJ, Tseng CC: Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med 2000;160:797-805.
12.
Godec CJ, Cass AS, Berkseth R: Emphysematous pyelonephritis in a solitary kidney. J Urol 1980;124:119-121.
13.
Morehouse HT, Weiner SN, Hoffman JC: Imaging in inflammatory disease of the kidney. Am J Roentgenol 1984;143:135-141.
14.
Abdul-Halim H, Kehinde EO, Abdeen S, Lashin I, Al-Hunayan AA, Al-Awadi KA: Severe emphysematous pyelonephritis in diabetic patients: diagnosis and aspects of surgical management. Urol Int 2005;75:123-128.
15.
Narlawar RS, Raut AA, Nagar A, Hira P, Hanchate V, Asrani A: Imaging features and guided drainage in emphysematous pyelonephritis: a study of 11 cases. Clin Radiol 2004;59:192-197.
16.
Ubee SS, McGlynn L, Fordham M: Emphysematous pyelonephritis. BJU Int 2011;107:1474-1478.
17.
Mallet M, Knockaert DC, Oyen RH, Van Poppel HP: Emphysematous pyelonephritis: no longer a surgical disease? Eur J Emerg Med 2002;9:266-269.
18.
Sugandh S: Emphysematous pyelonephritis. Medscape Reference (updated 1 May 2008). http://emedicine.medscape.com/article/457306-overview (accessed 1 October 2012).
19.
Park SB, Lee SJ, Kim YW, Huh JS, Kim JI, Chang SG: Outcome of nephrectomy and kidney-preserving procedures for the treatment of emphysematous pyelonephritis. Scand J Urol Nephrol 2006;40:332-338.
20.
Kuzgunbay B, Turunc T, Tokmak N, Turunc T, Dirim A, Aygun C, Ozkardes H: Tailored treatment approach for emphysematous pyelonephritis. Urol Int 2011;86:444-447.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.